Archives: Speakers

With over 35 years of clinical research experience, Peter brings medical, scientific, and business insights into oncology and hematology drug development. His understanding of the clinical development – ranging from feasibility assessments, medical monitoring oversight, regulatory strategy, and patient safety enables him to provide valuable guidance to our biopharma partners.

Peter holds an MD and PhD from Ludwig-Maximilians-Universität München

Adam brings nearly 30 years of experience and a strong record of building high-performing, global teams that drive clinical programs for regulatory approval and commercialization of therapies. Adam’s teams also bring an adeptness in molecule-to-market strategies and operational excellence. Adam ensures our ability to provide development strategies while delivering exceptional experiences for our clients conducting oncology, hematology and cell and gene therapy studies.

Adam holds Master of Science degrees in Biology and Clinical Psychology from the University of Washington and an MBA from Boise State University

Tariq is a Lead Clinic Trial Liaison at Regeneron responsible for expanding the clinical trial footprint in the region, providing key scientific insights and overseeing the successful delivery of oncology trials. With over 15 years of Oncology research experience, his leadership and strategic insight have fostered strong collaborations with the NHS, Private Hospitals, and research bodies such as the NIHR and Cancer Trials Office (Ireland).  These partnerships have driven impactful initiatives, with a view to significantly advancing oncology clinical research across UK and Ireland.

Dr. Marina Murphy is Senior Director of Scientific Affairs at Haypp Group, where she leads scientific communications and public health advocacy to support tobacco harm reduction. With over 20 years’ experience, she has held senior roles at Juul Labs, British American Tobacco, and ANDS, focusing on translating complex science into accessible, evidence-based narratives. Marina is a passionate advocate for transparent science communication and sound regulatory frameworks that support public health. A vocal proponent of evidence-based policy, she regularly addresses misinformation around nicotine products.

Marina holds a Ph.D. in chemistry from the National University of Ireland, Galway and a Masters in Science Communication for Dublin City University, Ireland.

Ross Henry Law is a reporter for GlobalData’s healthcare publications. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer’s disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.